Share this story:

CBD Global Sciences Launches Aethics Product line on the first and most popular European eCommerce CBD market platform

Denver, Colorado – TheNewswire - October 8, 2020 – CBD Global Sciences Inc. (CSE:CBDN) (OTC:CBDNF) (Frankfurt: GS3) (CNSX:CBDN.CN), (“CBD Global” or the “Company”), is pleased to announce the launch of its premier CBD product line – Aethics on the first and most popular European eCommerce CBD market platform – Mellow.



The Company will be launching a selection of its most popular Aethics CBD products on the Mellow Store site. The products will be available on the site in the UK, and throughout many other EU countries. Mellow provides a turnkey solution for access to the European CBD marketplace including regulatory compliance and payment and shipping support.  Mellows eCommerce CBD marketplace provides customers with the highest quality and reputable CBD brands and products. Products sold through their site are fully vetted by the company and must adhere to the highest level of quality control and industry testing.  


Europe’s CBD market is expected to boom over the next four years.  Leading market intelligence firm Brightfield Group estimated the market to be $318 million in 2018 and is estimated to grow over 400% through 2023.  "CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited. This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we're seeing in the U.S. With the Novel Foods Act, it is a challenging legal environment to operate in, but impending regulatory changes are likely to smooth the way for significant mid-term growth," Brightfield Managing Director, Bethany Gomez, highlights. CBD has been well received on a greater scale, especially in countries that already have medical or recreational cannabis programs and there are growing efforts in countries with no cannabis or CBD programs to have one or both in the coming years.* “

“We’re excited to be working in conjunction with Mellow Store to introduce our Aethics brand of products to the European markets” commented Brad Wyatt, President and CEO of CBD Global Sciences. “CBD Global Sciences is working hard to expand the footprint of our brands.  This is an excellent opportunity to showcase our high-quality CBD products in a part of the world experiencing a rapid increase in CBD sales”.


Mellow ( brings together consumers and quality CBD (cannabidiol) products from around the world in one fully managed marketplace. The main goal of the platform is also what inspired us to establish the company: meeting the need for a secure and trustworthy destination where online consumers can connect with and buy from the best brands from across the Globe. 


CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS ( and CANNAOIL (, which include CBD Oil tinctures (liquid products), CBD gummies, CBD topicals and CBD hydration products.  CBD Global’s hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows, and operates irrigated land in Colorado that grows hemp with only all-natural Colorado water, soil, sun and nutrients that is NEVER sprayed with pesticides or chemicals.  Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD.  The extraction/processing facility, operated by CBD Global, is located approximately 40 minutes from the farm.

*per Brightfield Group report dated March 26, 2019.

For further information, please contact Bruce Nurse, Investor Relations, (303) 919-2913,


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; and delay or failure to receive board, shareholder, or regulatory approvals.  Readers should not place undue reliance on forward-looking statements.  The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.